Clinical trial
A Dose Escalation Study of Intravenous L-citrulline in Steady-state Sickle Cell Disease
NCT02314689 is registered in ClinicalTrials.gov with Suvankar Majumdar as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Dose Escalation Study of Intravenous L-citrulline in Steady-state Sickle Cell Disease
- Lead sponsor
- Suvankar Majumdar
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 31, 2015
- Completion date
- December 31, 2015
- Enrollment
- 4 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
sickle cell disease